Enhanced oxidative stress and altered antioxidants in brains of Bcl-2- deficient mice

Journal of Neurochemistry

Volumn 71, Issue 2, 1998, Pages 741-748

  Hochman, Ayala ^a   Sternin, Hagit ^a   Gorodin, Svetlana ^b   Korsmeyer, Stanley ^c   Ziv, Ilan ^b   Melamed, Eldad ^b   Offen, Daniel ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Apoptosis; Bcl 2 deficient mice; Brain; Oxidative stress; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIOXIDANT; DOPAMINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; PARAQUAT; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; GLIA CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALIA;

EID: 0031724265     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71020741.x     Document Type: Article

References (76)

1. Abe K., Aoki M., Kawagoe J., Yoshida T., Hattori A., Kogure K., and Itoyama Y. (1995) Ischemic delayed neuronal death: a mitochondrial hypothesis. Stroke 26, 1478-1489.
2. Ali S. F., David S. N., Newport G. D., Cadet J. L., and Slikker W. Jr. (1994) MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels. Synapse 18, 27-34.
3. Baldessarini R. J., Kula N. S., Francoeur D., and Finklestein S. P. (1986) Antioxidants fail to inhibit depletion of striatal dopamine by MPTP [Letter]. Neurology 36, 735.
4. Battino M., Littarru G. P., Gorini A., and Villa R. F. (1996) Coenzyme Q, peroxidation and cytochrome oxidase features after Parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine. Neurochem. Res. 21, 505-514.
5. Bornkamm G. W. and Richter C. (1995) A link between the antioxidant defense system and calcium: a proposal for the biochemical function of Bcl-2. Curr. Top. Microbiol. Immunol. 194, 323-330.
6. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-254.
7. Buttke T. M. and Sandstrom P.A. (1994) Oxidative stress as a mediator of apoptosis. Immunol. Today 15, 7-10.
8. Carlberg I. and Mannervik B. (1985) Glutathione reductase. Methods Enzymol. 113, 484-499.
9. Chan P., DeLanney L. E., Irwin I., Langston J. W., and Di-Monte D. (1992) MPTP-induced ATP loss in mouse brain. Ann. NY Acad. Sci. 648, 306-308.
10. Davies A. (1995) The Bcl-2 family of proteins, and the regulation of neuronal survival. Trends Neurosci. 18, 355-358.
11. Desole M. S., Miele M., Esposito G., Fresu L. G., Migheli R., Zangani D., and Sircana S. (1995) Neuronal antioxidant system and MPTP-induced oxidative stress in the striatum and brain stem of the rat. Pharmacol. Biochem. Behav. 51, 581-592.
12. Ebadi M., Srinivasan S. K., and Baxi M. D. (1996) Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48, 1-19.
13. Ellerby L. M., Ellerby H. M., Park S. M., Holleran A. L., Murphy A. N., Fiskum G., Kane D. J., Testa M. P., Kayalar C., and Bredesen D. E. (1996) Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem. 67, 1259-1267.
14. Ellerby H. M., Martin S. J., Ellerby L. M., Naiem S. S., Rabizadeh S., Salvesen G. S., Casiano C. A., Cashman N. R., Green D. R., and Bredesen D. E. (1997) Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J. Neurosci. 17, 6165-6178.
15. Flohe L. and Gunzler W. A. (1984) Glutathione peroxidase. Methods Enzymol. 105, 115-121.
16. Gardner A. M., Xu F. H., Fady C., Sarafian T., Tu Y., and Lichtenstein A. (1997a) Evidence against the hypothesis that BCL-2 inhibits apoptosis through an anti-oxidant effect. Cell Death Differ. 4, 487-496.
17. Gardner A. M., Xu F. H., Fady C., Jacoby F. J., Duffey D. C., Tu Y., and Lichtenstein A. (1997b) Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic. Biol. Med. 22, 73-83.
18. Giala M. (1996) Hypoxic pretreatment protects against neuronal damage of the rat hippocampus induced by severe hypoxia. Brain Res. 714, 215-225.
19. Giardino I., Edelstein D., and Brownlee M. (1996) BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J. Clin. Invest. 97, 1422-1428.
20. Glover V., Gibb C., and Sandler M. (1986) Monoamine oxidase (MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissues. Neurosci. Lett. 64, 216-220.
21. Gorgias N., Maidatsi P., Tsolaki M., Alvanou A., Kiriazis G., Kaidoglou K., Greenlund L. J., Deckwerth T. L., and Johnson E. M. Jr. (1996) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14, 303-315.
22. Greenlund L. J. S., Deckwerth T. L., and Johnson E. M. Jr. (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14, 303-315.
23. Habig W. H., Pabst M. J., and Jacoby W. B. (1974) Glutathione S-transferases. J. Biol. Chem. 249, 7130-7139.
24. Hacker G. and Vaux D. L. (1995) A sticky business. Curr. Biol 5, 622-623.
25. Hagar H., Ueda N., and Shah S. V. (1996) Role of reactive oxygen metabolites in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells. Am. J. Physiol. 27, F209-F215.
26. Hirsch T., Marzo I., and Kroemer G. (1997) Role of the mitochondrial permeability transition pore in apoptosis. Biosci. Rep. 17, 67-76.
27. Hockenbery D. M., Nunez G., Milliman C. L., Schreiber R. D., and Korsmeyer S. J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336.
28. Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L., and Korsmeyer S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
29. Jacobson M. D. (1996) Reactive oxygen species and programmed cell death. Trends Biochem. Sci. 21, 83-86.
30. Jacobson M. D. and Raff M. C. (1995) Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374, 814-816.
31. Jacobson M. D., Burne J. F., King M. P., Miyashita T., Reed J. C., and Raff M. C. (1993) Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361, 365-368.
32. Javitch J. A. (1984) Uptake of MPP (+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. Eur. J. Pharmacol. 106, 455-456.
33. Kamada S., Shimono A., Shinto Y., Tsujimura T., Takahashi T., Noda T., Kitamura Y., Kondoh H., and Tsujimoto Y. (1995) Bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res. 55, 354-359.
34. Kane D. J., Sarafian T. A., Anton R., Hahn H., Gralla E. B., Valentine J. S., Ord T., and Bredesen D. E. (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274-1277.
35. Kayanoki Y., Fujii J., Islam K. N., Suzuki K., Kawata S., Matsuzawa Y., and Taniguchi N. (1996) The protective role of glutathione peroxidase in apoptosis induced by reactive oxygen species. J. Biochem. (Tokyo) 119, 817-822.
36. Kerr J. F. R., Wyllie A. H., and Currie A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
37. Kluck R. M., Bossy-Wetzel E., Gree D. R., and Newmeyer D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136.
38. Korsmeyer S. J. (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80, 879-886.
39. Korsmeyer S. J., Yin X. M., Oltvai Z. N., Veis-Novack D. J., and Linette G. P. (1995) Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim. Biophys. Acta 1271, 63-66.
40. LeGrand T. S. and Aw T. Y. (1996) Chronic hypoxia and glutathione-dependent detoxication in rat small intestine. Am. J. Physiol. 270, G725-G729.
41. Lithgow T., van Driel R., Bertram J. F., and Strasser A. (1994) The protein product of the oncogene Bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Cell Growth Differ. 5, 411-417.
42. Liu X., Kirn C. N., Yang J., Jemmerson R., and Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157.
43. Malmstrom B. G. (1982) Enzymology of oxygen. Annu. Rev. Biochem. 51, 21-59.
44. Marchetti P., Castedo M., Susin S. A., Zamzami N., Hirsch T., Macho A., Haeffner A., Hirsch F., Geuskens M., and Kroemer G. (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184, 1155-1160.
45. Martinovits G., Melamed E., Cohen O., Rosenthal J., and Uzzan A. (1986) Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP). Neurosci. Lett. 69, 192-197.
46. Merry E. D., Veis D. J., Hickey W. F., and Korsmeyer S. J. (1994) Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120, 301-311.
47. Mihatsch W., Russ H., Gerlach M., Riederer P., and Przuntek H. (1991) Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations. J. Neural Transm. 3, 73-78.
48. Mochizuki H., Goto K., Mori H., and Mizuno Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neural. Sci. 137, 120-123.
49. + and mitochondrial function. Life Sci. 40, 721-729.
50. Offen D., Ziv I., Gorodin S., Barzilai A., Malik A., and Melamed E. (1995) Dopamine-induced programmed cell death in mouse thymocytes. Biochim. Biophys. Acta 1268, 171-177.
51. Offen D., Ziv I., Sternin H., Melamed E., and Hochman A. (1996) Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp. Neurol. 141, 32-39.
52. Offen D., Ziv I., Panet H., Wasserman E., Stein R., Melamed E., and Barzilai A. (1997) Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2: evidence that the proto-oncogene may act as an antioxidant. Mol. Cell. Neurol. 17, 289-304.
53. Olanow C. W. (1992) An introduction to the free radical hypothesis in Parkinson's disease. Ann. Neurol. 35, S2-S9.
54. Perry T. L., Yong V. W., Clavier R. M., Jones K., Wright J. M., Foulks J. G., and Wall R. A. (1985) Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1.2,3,6-tetrahydropyridine by four different antioxidants in the mouse. Neurosci. Lett. 60, 109-114.
55. Perry T. L., Yong V. W., Hansen S., Jones K., Bergeron C., Foulks J. G., and Wright J. M. (1987) Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurol. Sci. 8, 321-331.
56. Petit P. X., Susin S.-A., Zamzami N., Mignotte B., and Kroemer G. (1996) Mitochondria and programmed cell death: back to the future. FEBS Lett. 396, 7-13.
57. Ramsey R. R. and Singer T. P. (1986) Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria. J. Biol. Chem. 261, 7585-7587.
58. Reed J. C. (1997) Cytochrome c: can't live with it - can't live without it. Cell 91, 559-562.
59. Shimizu S., Eguchi Y., Kosaka H., Kamiike W., Matsuda H., and Tsujimoto Y. (1995) Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374, 811-813.
60. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., and Tsujimoto Y. (1996) Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13, 21-29.
61. Slater A. F., Stefan C., Nobel I., van-den Dobbelsteen D. J., and Orrenius S. (1995) Signalling mechanisms and oxidative stress in apoptosis. Toxicol. Lett. 82-83, 149-153.
62. Steller H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445-1449.
63. Stern G. (1996) Parkinson's disease. The apoptosis hypothesis. Adv. Neural. 69, 101-107.
64. Sutphin M. S. and Buckman T. D. (1991) Effects of low selenium diets on antioxidant status and MPTP toxicity in mice. Neurochem. Res. 16, 1257-1263.
65. Talley A. K., Dewhurst S., Perry S. W., Dollard S. C., Gummuluru S., Fine S. M., New D., Epstein L. G., Gendelman H. E., and Gelbard H.A. (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes Bcl-2 and crmA. Mol. Cell. Biol. 15, 2359-2366.
66. Thiffault C., Aumont N., Quirion R., and Poirier J (1995) Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J. Neurochem. 65, 2725-2733.
67. Tompkins M. M., Basgall E. J., Zamrini E., and Hill W. D. (1997) Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigrai neurons. Am. J. Pathol. 150, 119-131.
68. Troy C. M., Stefanis L., Prochiantz A., Greene L. A., and Shelanski M. L. (1996) The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc Superoxide dismutase down-regulation. Proc. Natl. Acad. Sci. USA 93, 5635-5640.
69. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627-637.
70. Veis D. J., Sorenson C. M., Shutter J. R., and Korsmeyer S. J. (1995) Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 75, 229-240.
71. Verity M. A. (1994) Oxidative damage and repair in the developing nervous system. Neurotoxicology 15, 81-92.
72. Wyllie A. H. (1995) The genetic regulation of apoptosis. Curr. Opin. Genet. Dev. 5, 97-104.
73. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S. A., Petit P. X., Mignotte B., and Kroemer G. (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
74. Zamzami N., Hirsch T., Dallaporta B., Petit P. X., and Kroemer G. (1997) Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomembr. 29, 185-193.
75. Zhong L. T., Sarafian T., Kane D. J., Charles A. C., Mah S. P., Edwards R. H., and Bredesen D. E. (1993) Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90, 4533-4537.
76. Ziv I., Melamed E., Nardi N., Luria D., Achiron A., Offen D., and Barzilai A. (1994) Dopamine induces apoptosis like cell death in cultured sympathetic neurons: a possible novel pathogenic mechanism in Parkinson's disease. Neurosci. Lett. 170, 136-140.